Tim Matthew Bernard

Cellexus International Ltd. offers a personalized solution for each client with their revolutionary, market-leading single-use airlift bioreactor systems. The company is based in Forfar, UK. The British company's technology is designed to improve cell culture and fermentation processes, and their CellMaker range has been proven successful for cell culture, microbial fermentations, and phage applications. The company was founded in 2017 by Kevin A. Auton, and Gavin William Valentine Hands has been the CEO of the company since 2017.

Medix Biochemica Oy Ab develops, produces, and markets monoclonal antibodies, antibody services, and recombinant antigens for in vitro diagnostics industry. It also provides rapid tests for human healthcare. The company was founded in 1985 and is headquartered in Espoo, Finland.